{"schemaVersion":"ready-scan.discovery-entity.v3","id":"urn:readyscan:entity:myneo-therapeutics-q138845336","slug":"myneo-therapeutics-q138845336","kind":"entity","entityType":"Organization","canonicalUrl":"https://directory.readyscan.ai/entities/myneo-therapeutics-q138845336","machineUrl":"https://directory.readyscan.ai/discovery/entities/myneo-therapeutics-q138845336.json","llmsUrl":"https://directory.readyscan.ai/entities/myneo-therapeutics-q138845336/llms.txt","name":"myNEO Therapeutics","alternateNames":[],"websiteUrl":"https://www.myneotx.com","category":{"slug":"businesses","name":"Businesses","canonicalUrl":"https://directory.readyscan.ai/directory/businesses"},"description":"Belgian biotechnology company specializing in AI-driven neoantigen discovery and cancer immunotherapy, founded in 2018 in Ghent, Belgium.","summary":"myNEO Therapeutics: Belgian biotechnology company specializing in AI-driven neoantigen discovery and cancer immunotherapy, founded in 2018 in Ghent, Belgium. Website: https://www.myneotx.com","localizedDescriptions":[],"claims":[{"id":"source-description","label":"About","value":"Belgian biotechnology company specializing in AI-driven neoantigen discovery and cancer immunotherapy, founded in 2018 in Ghent, Belgium.","sourceIds":["source-record"]},{"id":"source-listed-website","label":"Website","value":"https://www.myneotx.com","sourceIds":["source-record"]}],"knowledge":{"offerings":[],"answers":[],"developments":[]},"sources":[{"id":"source-record","title":"myNEO Therapeutics — Wikidata Q138845336","publisher":"Wikidata","url":"https://www.wikidata.org/wiki/Special:EntityData/Q138845336.json?revision=2482446248","accessedOn":"2026-07-29"},{"id":"source-attribution","title":"Wikidata data access","publisher":"Wikidata","url":"https://www.wikidata.org/wiki/Help:Data_access","accessedOn":"2026-07-29"},{"id":"permission-evidence","title":"Wikidata reuse permission","publisher":"Wikidata","url":"https://www.wikidata.org/wiki/Wikidata:Licensing","accessedOn":"2026-07-29"},{"id":"reuse-license","title":"CC0 1.0 Universal","publisher":"Wikidata","url":"https://creativecommons.org/publicdomain/zero/1.0/","accessedOn":"2026-07-29"}],"ownership":{"state":"public_sourced_unclaimed","notice":"Public-source record; owner verification is not claimed.","provenance":{"snapshotId":"wikidata-organization-frontier-2026-07-29","sourceId":"wikidata","sourceRecordId":"Q138845336","sourceRevisionId":"wdqs-sha256-3c17642f1bbfdea676527ee9fdfb40ac17a53047a47c16f94b486c07ab46b6e5","sourceContentHash":"fnv1a64:44c4becbd7af8292","recordRevisionId":"2482446248","recordContentHash":"fnv1a64:cc0b015d255d27f9","sourceCanonicalUrl":"https://www.wikidata.org/wiki/Special:EntityData/Q138845336.json?revision=2482446248","sourceModifiedAt":"2026-04-17T13:59:32Z","observedOn":"2026-07-29","permission":{"basis":"cc0","evidenceUrl":"https://www.wikidata.org/wiki/Wikidata:Licensing","license":{"spdxId":"CC0-1.0","name":"CC0 1.0 Universal","url":"https://creativecommons.org/publicdomain/zero/1.0/"}},"attributionUrl":"https://www.wikidata.org/wiki/Help:Data_access"}},"datePublished":"2026-07-29","dateModified":"2026-07-29","contentFingerprint":"fnv1a64:d72fb2536ad1cf53","revision":"fnv1a64:0cd7d1719c7e6979","agentProtocol":{"discovery":"https://readyscan.ai/api/v1/ai-search/discovery","evidence":"https://readyscan.ai/api/v1/ai-search/entities/myneo-therapeutics-q138845336/evidence"},"structuredData":{"@context":"https://schema.org","@id":"https://directory.readyscan.ai/entities/myneo-therapeutics-q138845336#entity","name":"myNEO Therapeutics","identifier":"urn:readyscan:entity:myneo-therapeutics-q138845336","description":"Belgian biotechnology company specializing in AI-driven neoantigen discovery and cancer immunotherapy, founded in 2018 in Ghent, Belgium.","url":"https://www.myneotx.com","mainEntityOfPage":"https://directory.readyscan.ai/entities/myneo-therapeutics-q138845336","datePublished":"2026-07-29","dateModified":"2026-07-29","citation":["https://www.wikidata.org/wiki/Special:EntityData/Q138845336.json?revision=2482446248","https://www.wikidata.org/wiki/Help:Data_access","https://www.wikidata.org/wiki/Wikidata:Licensing","https://creativecommons.org/publicdomain/zero/1.0/"],"additionalProperty":[{"@type":"PropertyValue","propertyID":"ownership-state","name":"Ownership state","value":"public_sourced_unclaimed"},{"@type":"PropertyValue","propertyID":"content-fingerprint","name":"Material content fingerprint","value":"fnv1a64:d72fb2536ad1cf53"},{"@type":"PropertyValue","propertyID":"source-record","name":"Source record","value":"wikidata/Q138845336"},{"@type":"PropertyValue","propertyID":"source-revision","name":"Source revision","value":"2482446248"},{"@type":"PropertyValue","propertyID":"reuse-license","name":"Reuse license","value":"CC0-1.0"},{"@type":"PropertyValue","propertyID":"claim:source-description","name":"About","value":"Belgian biotechnology company specializing in AI-driven neoantigen discovery and cancer immunotherapy, founded in 2018 in Ghent, Belgium."},{"@type":"PropertyValue","propertyID":"claim:source-listed-website","name":"Website","value":"https://www.myneotx.com"}],"@type":"Organization"}}